$OFIX News

Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18

Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15

Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $15

Orthofix Medical Inc. 2026 Q1 - Results - Earnings Call Presentation

Orthofix Medical Announces New Pediatric Limb Reconstruction Innovations That Expand Treatment Options For Pediatric And Small Stature Patients

Orthofix Medical Inc. (NASDAQ:OFIX) Reports Mixed Q1 as Sales Miss Estimates, Loss Narrows; Full-Year Outlook Reaffirmed

Orthofix Medical Inc. (OFIX) Q1 2026 Earnings Call Transcript

Full Transcript: Orthofix Medical Q1 2026 Earnings Call

Orthofix Medical Affirms FY2026 Sales Guidance of $850.000M-$860.000M vs $855.606M Est

Orthofix Medical Q1 Adj. EPS $(0.13) Beats $(0.68) Estimate, Sales $196.700M Beat $193.985M Estimate

Orthofix Reaffirms FY26 Net Sales Outlook Of $850M-$860M; Reports Preliminary Q1 Net Sales Of ~$196.7M, And Non-GAAP Pro Forma Net Sales Of ~$196.4M

A Glimpse Into The Expert Outlook On Orthofix Medical Through 5 Analysts

Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $18

Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $20

Orthofix Medical Inc (NASDAQ:OFIX) Posts Strong Q4 Profit Beat Despite Revenue Miss, Provides 2026 Outlook

Orthofix Medical Inc. (OFIX) Q4 2025 Earnings Call Transcript

Orthofix Medical Inc. 2025 Q4 - Results - Earnings Call Presentation

Orthofix Medical Earnings Review: Q4 Summary

Orthofix Medical Sees FY2026 Sales $850.000M-$860.000M vs $862.758M Est

Orthofix Medical Q4 Adj. EPS $0.24 Beats $0.12 Estimate, Sales $219.911M Beat $218.861M Estimate.